Deftereos et al., JAMA Network Open,
doi:10.1001/jamanetworkopen.2020.13136 (Peer Reviewed)
Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalized With Coronavirus Disease 2019: The GRECCO-19 Randomized Clinical Trial
RCT with 55 patients treated with colchicine and 50 control patients, showing lower mortality and ventilation with treatment.
NCT04326790.
Deftereos et al., 6/24/2020, Randomized Controlled Trial, Greece, Europe, peer-reviewed, 49 authors.
risk of death, 77.3% lower, RR 0.23, p = 0.19, treatment 1 of 55 (1.8%), control 4 of 50 (8.0%).
risk of mechanical ventilation, 81.8% lower, RR 0.18, p = 0.10, treatment 1 of 55 (1.8%), control 5 of 50 (10.0%).
risk of clinical deterioration, 87.4% lower, RR 0.13, p = 0.05, treatment 1 of 55 (1.8%), control 7 of 50 (14.0%), odds ratio converted to relative risk.
Effect extraction follows
pre-specified rules
prioritizing more serious outcomes. For an individual study the most serious
outcome may have a smaller number of events and lower statistical signficance,
however this provides the strongest evidence for the most serious outcomes
when combining the results of many trials.